Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 111

1.

New Guidelines for Statistical Reporting in the Journal.

Harrington D, D'Agostino RB Sr, Gatsonis C, Hogan JW, Hunter DJ, Normand ST, Drazen JM, Hamel MB.

N Engl J Med. 2019 Jul 18;381(3):285-286. doi: 10.1056/NEJMe1906559. No abstract available.

PMID:
31314974
2.

Micronodules Detected on Computed Tomography During the National Lung Screening Trial: Prevalence and Relation to Positive Studies and Lung Cancer.

Munden RF, Chiles C, Boiselle PM, Sicks JD, Aberle DR, Gatsonis CA.

J Thorac Oncol. 2019 Sep;14(9):1538-1546. doi: 10.1016/j.jtho.2019.05.045. Epub 2019 Jul 8.

PMID:
31295576
3.

Association of Amyloid Positron Emission Tomography With Subsequent Change in Clinical Management Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia.

Rabinovici GD, Gatsonis C, Apgar C, Chaudhary K, Gareen I, Hanna L, Hendrix J, Hillner BE, Olson C, Lesman-Segev OH, Romanoff J, Siegel BA, Whitmer RA, Carrillo MC.

JAMA. 2019 Apr 2;321(13):1286-1294. doi: 10.1001/jama.2019.2000.

4.

Association of Magnetic Resonance Imaging and a 12-Gene Expression Assay With Breast Ductal Carcinoma In Situ Treatment.

Lehman CD, Gatsonis C, Romanoff J, Khan SA, Carlos R, Solin LJ, Badve S, McCaskill-Stevens W, Corsetti RL, Rahbar H, Spell DW, Blankstein KB, Han LK, Sabol JL, Bumberry JR, Gareen I, Snyder BS, Wagner LI, Miller KD, Sparano JA, Comstock C.

JAMA Oncol. 2019 Jul 1;5(7):1036-1042. doi: 10.1001/jamaoncol.2018.6269.

PMID:
30653209
5.

Combining biomarker trajectories to improve diagnostic accuracy in prospective cohort studies with verification bias.

Li H, Gatsonis C.

Stat Med. 2019 May 20;38(11):1968-1990. doi: 10.1002/sim.8079. Epub 2018 Dec 27.

PMID:
30590870
6.

Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies: The PRISMA-DTA Statement.

McInnes MDF, Moher D, Thombs BD, McGrath TA, Bossuyt PM; the PRISMA-DTA Group, Clifford T, Cohen JF, Deeks JJ, Gatsonis C, Hooft L, Hunt HA, Hyde CJ, Korevaar DA, Leeflang MMG, Macaskill P, Reitsma JB, Rodin R, Rutjes AWS, Salameh JP, Stevens A, Takwoingi Y, Tonelli M, Weeks L, Whiting P, Willis BH.

JAMA. 2018 Jan 23;319(4):388-396. doi: 10.1001/jama.2017.19163.

PMID:
29362800
7.

Impact of Coronary Computed Tomography Angiography Findings on Initiation of Cardioprotective Medications.

Chang AM, Litt HI, Snyder BS, Gatsonis C, Greco EM, Miller CD, Singh H, O'Conor KJ, Hollander JE.

Circulation. 2017 Nov 28;136(22):2195-2197. doi: 10.1161/CIRCULATIONAHA.117.029994. No abstract available.

PMID:
29180497
8.

STARD for Abstracts: essential items for reporting diagnostic accuracy studies in journal or conference abstracts.

Cohen JF, Korevaar DA, Gatsonis CA, Glasziou PP, Hooft L, Moher D, Reitsma JB, de Vet HC, Bossuyt PM; STARD Group.

BMJ. 2017 Aug 17;358:j3751. doi: 10.1136/bmj.j3751. No abstract available.

PMID:
28819063
9.

Facilitating Prospective Registration of Diagnostic Accuracy Studies: A STARD Initiative.

Korevaar DA, Hooft L, Askie LM, Barbour V, Faure H, Gatsonis CA, Hunter KE, Kressel HY, Lippman H, McInnes MDF, Moher D, Rifai N, Cohen JF, Bossuyt PMM.

Clin Chem. 2017 Aug;63(8):1331-1341. doi: 10.1373/clinchem.2017.272765. Epub 2017 Jun 19. No abstract available.

10.

Clinical risk factors alone are inadequate for predicting significant coronary artery disease.

Korley FK, Gatsonis C, Snyder BS, George RT, Abd T, Zimmerman SL, Litt HI, Hollander JE.

J Cardiovasc Comput Tomogr. 2017 Jul - Aug;11(4):309-316. doi: 10.1016/j.jcct.2017.04.011. Epub 2017 Apr 27.

PMID:
28487137
11.

STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration.

Cohen JF, Korevaar DA, Altman DG, Bruns DE, Gatsonis CA, Hooft L, Irwig L, Levine D, Reitsma JB, de Vet HC, Bossuyt PM.

BMJ Open. 2016 Nov 14;6(11):e012799. doi: 10.1136/bmjopen-2016-012799.

12.

PRagmatic trial Of Video Education in Nursing homes: The design and rationale for a pragmatic cluster randomized trial in the nursing home setting.

Mor V, Volandes AE, Gutman R, Gatsonis C, Mitchell SL.

Clin Trials. 2017 Apr;14(2):140-151. doi: 10.1177/1740774516685298. Epub 2017 Jan 9.

13.

MR spectroscopy of breast cancer for assessing early treatment response: Results from the ACRIN 6657 MRS trial.

Bolan PJ, Kim E, Herman BA, Newstead GM, Rosen MA, Schnall MD, Pisano ED, Weatherall PT, Morris EA, Lehman CD, Garwood M, Nelson MT, Yee D, Polin SM, Esserman LJ, Gatsonis CA, Metzger GJ, Newitt DC, Partridge SC, Hylton NM; ACRIN Trial team ISPY-1 Investigators.

J Magn Reson Imaging. 2017 Jul;46(1):290-302. doi: 10.1002/jmri.25560. Epub 2016 Dec 16.

14.

Rationale and design of the Randomized Evaluation of patients with Stable angina Comparing Utilization of noninvasive Examinations (RESCUE) trial.

Stillman AE, Gatsonis C, Lima JA, Black WC, Cormack J, Gareen I, Hoffmann U, Liu T, Mavromatis K, Schnall MD, Udelson JE, Woodard PK.

Am Heart J. 2016 Sep;179:19-28. doi: 10.1016/j.ahj.2016.06.003. Epub 2016 Jun 17.

15.

Updating standards for reporting diagnostic accuracy: the development of STARD 2015.

Korevaar DA, Cohen JF, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig L, Moher D, de Vet HCW, Altman DG, Hooft L, Bossuyt PMM.

Res Integr Peer Rev. 2016 Jun 7;1:7. doi: 10.1186/s41073-016-0014-7. eCollection 2016.

16.

Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial.

Patz EF Jr, Greco E, Gatsonis C, Pinsky P, Kramer BS, Aberle DR.

Lancet Oncol. 2016 May;17(5):590-9. doi: 10.1016/S1470-2045(15)00621-X. Epub 2016 Mar 18.

17.

STARD 2015: updated reporting guidelines for all diagnostic accuracy studies.

Bossuyt PM, Cohen JF, Gatsonis CA, Korevaar DA; STARD group.

Ann Transl Med. 2016 Feb;4(4):85. doi: 10.3978/j.issn.2305-5839.2016.02.06. No abstract available.

18.

Neoadjuvant Chemotherapy for Breast Cancer: Functional Tumor Volume by MR Imaging Predicts Recurrence-free Survival-Results from the ACRIN 6657/CALGB 150007 I-SPY 1 TRIAL.

Hylton NM, Gatsonis CA, Rosen MA, Lehman CD, Newitt DC, Partridge SC, Bernreuter WK, Pisano ED, Morris EA, Weatherall PT, Polin SM, Newstead GM, Marques HS, Esserman LJ, Schnall MD; ACRIN 6657 Trial Team and I-SPY 1 TRIAL Investigators.

Radiology. 2016 Apr;279(1):44-55. doi: 10.1148/radiol.2015150013. Epub 2015 Dec 1.

19.

STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies.

Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig L, Lijmer JG, Moher D, Rennie D, de Vet HC, Kressel HY, Rifai N, Golub RM, Altman DG, Hooft L, Korevaar DA, Cohen JF; STARD Group.

BMJ. 2015 Oct 28;351:h5527. doi: 10.1136/bmj.h5527. No abstract available.

20.

STARD 2015: An Updated List of Essential Items for Reporting Diagnostic Accuracy Studies.

Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig L, Lijmer JG, Moher D, Rennie D, de Vet HC, Kressel HY, Rifai N, Golub RM, Altman DG, Hooft L, Korevaar DA, Cohen JF; STARD Group.

Clin Chem. 2015 Dec;61(12):1446-52. doi: 10.1373/clinchem.2015.246280. Epub 2015 Oct 28.

21.

STARD 2015: An Updated List of Essential Items for Reporting Diagnostic Accuracy Studies.

Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig L, Lijmer JG, Moher D, Rennie D, de Vet HC, Kressel HY, Rifai N, Golub RM, Altman DG, Hooft L, Korevaar DA, Cohen JF; STARD Group.

Radiology. 2015 Dec;277(3):826-32. doi: 10.1148/radiol.2015151516. Epub 2015 Oct 28.

PMID:
26509226
22.

Coronary Computed Tomography Angiography Versus Traditional Care: Comparison of One-Year Outcomes and Resource Use.

Hollander JE, Gatsonis C, Greco EM, Snyder BS, Chang AM, Miller CD, Singh H, Litt HI.

Ann Emerg Med. 2016 Apr;67(4):460-468.e1. doi: 10.1016/j.annemergmed.2015.09.014. Epub 2015 Oct 23.

PMID:
26507904
23.

Metrology Standards for Quantitative Imaging Biomarkers.

Sullivan DC, Obuchowski NA, Kessler LG, Raunig DL, Gatsonis C, Huang EP, Kondratovich M, McShane LM, Reeves AP, Barboriak DP, Guimaraes AR, Wahl RL; RSNA-QIBA Metrology Working Group.

Radiology. 2015 Dec;277(3):813-25. doi: 10.1148/radiol.2015142202. Epub 2015 Aug 12.

24.

Reply: Repeatability of Tumor SUV Quantification: The Role of Variable Blood SUV.

Weber WA, Gatsonis C, Siegel B.

J Nucl Med. 2015 Oct;56(10):1636. doi: 10.2967/jnumed.115.162271. Epub 2015 Aug 6. No abstract available.

25.

Patient willingness for repeat screening and preference for CT colonography and optical colonoscopy in ACRIN 6664: the National CT Colonography trial.

Gareen IF, Siewert B, Vanness DJ, Herman B, Johnson CD, Gatsonis C.

Patient Prefer Adherence. 2015 Jul 23;9:1043-51. doi: 10.2147/PPA.S81901. eCollection 2015.

26.

Airflow Limitation and Histology Shift in the National Lung Screening Trial. The NLST-ACRIN Cohort Substudy.

Young RP, Duan F, Chiles C, Hopkins RJ, Gamble GD, Greco EM, Gatsonis C, Aberle D.

Am J Respir Crit Care Med. 2015 Nov 1;192(9):1060-7. doi: 10.1164/rccm.201505-0894OC.

27.

Repeatability of 18F-FDG PET/CT in Advanced Non-Small Cell Lung Cancer: Prospective Assessment in 2 Multicenter Trials.

Weber WA, Gatsonis CA, Mozley PD, Hanna LG, Shields AF, Aberle DR, Govindan R, Torigian DA, Karp JS, Yu JQ, Subramaniam RM, Halvorsen RA, Siegel BA; ACRIN 6678 Research team; MK-0646-008 Research team.

J Nucl Med. 2015 Aug;56(8):1137-43. doi: 10.2967/jnumed.114.147728. Epub 2015 Apr 23.

28.

Performance of the 2-hour accelerated diagnostic protocol within the American College of Radiology Imaging Network PA 4005 cohort.

Mahler SA, Miller CD, Litt HI, Gatsonis CA, Snyder BS, Hollander JE.

Acad Emerg Med. 2015 Apr;22(4):452-60. doi: 10.1111/acem.12621. Epub 2015 Mar 24.

29.

Cost-effectiveness of CT screening in the National Lung Screening Trial.

Black WC, Gareen IF, Soneji SS, Sicks JD, Keeler EB, Aberle DR, Naeim A, Church TR, Silvestri GA, Gorelick J, Gatsonis C; National Lung Screening Trial Research Team.

N Engl J Med. 2014 Nov 6;371(19):1793-802. doi: 10.1056/NEJMoa1312547.

30.

Impact of lung cancer screening results on participant health-related quality of life and state anxiety in the National Lung Screening Trial.

Gareen IF, Duan F, Greco EM, Snyder BS, Boiselle PM, Park ER, Fryback D, Gatsonis C.

Cancer. 2014 Nov 1;120(21):3401-9. doi: 10.1002/cncr.28833. Epub 2014 Jul 25.

31.

A flexible, multifaceted approach is needed in health technology assessment of PET.

Dahabreh IJ, Gatsonis C.

J Nucl Med. 2014 Aug;55(8):1225-7. doi: 10.2967/jnumed.114.142331. Epub 2014 Jul 21. No abstract available.

32.

Contralateral prophylactic mastectomy in the American College of Radiology Imaging Network 6667 trial: effect of breast MR imaging assessments and patient characteristics.

Rahbar H, Hanna LG, Gatsonis C, Mahoney MC, Schnall MD, DeMartini WB, Lehman CD.

Radiology. 2014 Oct;273(1):53-60. doi: 10.1148/radiol.14132029. Epub 2014 Jun 16.

33.

Quantitative imaging biomarkers: a review of statistical methods for technical performance assessment.

Raunig DL, McShane LM, Pennello G, Gatsonis C, Carson PL, Voyvodic JT, Wahl RL, Kurland BF, Schwarz AJ, Gönen M, Zahlmann G, Kondratovich MV, O'Donnell K, Petrick N, Cole PE, Garra B, Sullivan DC; QIBA Technical Performance Working Group.

Stat Methods Med Res. 2015 Feb;24(1):27-67. doi: 10.1177/0962280214537344. Epub 2014 Jun 11. Review.

34.

Overdiagnosis in low-dose computed tomography screening for lung cancer.

Patz EF Jr, Pinsky P, Gatsonis C, Sicks JD, Kramer BS, Tammemägi MC, Chiles C, Black WC, Aberle DR; NLST Overdiagnosis Manuscript Writing Team.

JAMA Intern Med. 2014 Feb 1;174(2):269-74. doi: 10.1001/jamainternmed.2013.12738. Erratum in: JAMA Intern Med. 2014 May;174(5):828.

35.

Results of the two incidence screenings in the National Lung Screening Trial.

Aberle DR, DeMello S, Berg CD, Black WC, Brewer B, Church TR, Clingan KL, Duan F, Fagerstrom RM, Gareen IF, Gatsonis CA, Gierada DS, Jain A, Jones GC, Mahon I, Marcus PM, Rathmell JM, Sicks J; National Lung Screening Trial Research Team.

N Engl J Med. 2013 Sep 5;369(10):920-31. doi: 10.1056/NEJMoa1208962.

36.

Positron emission tomography/computed tomography identification of clear cell renal cell carcinoma: results from the REDECT trial.

Divgi CR, Uzzo RG, Gatsonis C, Bartz R, Treutner S, Yu JQ, Chen D, Carrasquillo JA, Larson S, Bevan P, Russo P.

J Clin Oncol. 2013 Jan 10;31(2):187-94. doi: 10.1200/JCO.2011.41.2445. Epub 2012 Dec 3. Erratum in: J Clin Oncol. 2018 Jan 1;36(1):98.

37.

Efficiency of study designs in diagnostic randomized clinical trials.

Lu B, Gatsonis C.

Stat Med. 2013 Apr 30;32(9):1451-66. doi: 10.1002/sim.5655. Epub 2012 Oct 15.

38.

Assessing the stand-alone sensitivity of computer-aided detection with cancer cases from the Digital Mammographic Imaging Screening Trial.

Cole EB, Zhang Z, Marques HS, Nishikawa RM, Hendrick RE, Yaffe MJ, Padungchaichote W, Kuzmiak C, Chayakulkheeree J, Conant EF, Fajardo LL, Baum J, Gatsonis C, Pisano E.

AJR Am J Roentgenol. 2012 Sep;199(3):W392-401. doi: 10.2214/AJR.11.7255.

39.

Evaluation of tissue sampling methods used for MRI-detected contralateral breast lesions in the American College of Radiology Imaging Network 6667 trial.

DeMartini WB, Hanna L, Gatsonis C, Mahoney MC, Lehman CD.

AJR Am J Roentgenol. 2012 Sep;199(3):W386-91. doi: 10.2214/AJR.11.7000.

40.

Dynamic Optimal Strategy for Monitoring Disease Recurrence.

Li H, Gatsonis C.

Sci China Math. 2012 Aug 1;55(8):1565-182.

41.

On ROC analysis with nonbinary reference standard.

Shiu SY, Gatsonis C.

Biom J. 2012 Jul;54(4):457-80. doi: 10.1002/bimj.201100206. Epub 2012 May 29.

PMID:
22641278
42.

Positive predictive value of BI-RADS MR imaging.

Mahoney MC, Gatsonis C, Hanna L, DeMartini WB, Lehman C.

Radiology. 2012 Jul;264(1):51-8. doi: 10.1148/radiol.12110619. Epub 2012 May 15.

43.

CT angiography for safe discharge of patients with possible acute coronary syndromes.

Litt HI, Gatsonis C, Snyder B, Singh H, Miller CD, Entrikin DW, Leaming JM, Gavin LJ, Pacella CB, Hollander JE.

N Engl J Med. 2012 Apr 12;366(15):1393-403. doi: 10.1056/NEJMoa1201163. Epub 2012 Mar 26.

44.

ACRIN 6665/RTOG 0132 phase II trial of neoadjuvant imatinib mesylate for operable malignant gastrointestinal stromal tumor: monitoring with 18F-FDG PET and correlation with genotype and GLUT4 expression.

Van den Abbeele AD, Gatsonis C, de Vries DJ, Melenevsky Y, Szot-Barnes A, Yap JT, Godwin AK, Rink L, Huang M, Blevins M, Sicks J, Eisenberg B, Siegel BA.

J Nucl Med. 2012 Apr;53(4):567-74. doi: 10.2967/jnumed.111.094425. Epub 2012 Mar 1.

45.

The National CT Colonography Trial: assessment of accuracy in participants 65 years of age and older.

Johnson CD, Herman BA, Chen MH, Toledano AY, Heiken JP, Dachman AH, Kuo MD, Menias CO, Siewert B, Cheema JI, Obregon R, Fidler JL, Zimmerman P, Horton KM, Coakley KJ, Iyer RB, Hara AK, Halvorsen RA Jr, Casola G, Yee J, Blevins M, Burgart LJ, Limburg PJ, Gatsonis CA.

Radiology. 2012 May;263(2):401-8. doi: 10.1148/radiol.12102177. Epub 2012 Feb 23.

46.

Annual screening strategies in BRCA1 and BRCA2 gene mutation carriers: a comparative effectiveness analysis.

Lowry KP, Lee JM, Kong CY, McMahon PM, Gilmore ME, Cott Chubiz JE, Pisano ED, Gatsonis C, Ryan PD, Ozanne EM, Gazelle GS.

Cancer. 2012 Apr 15;118(8):2021-30. doi: 10.1002/cncr.26424. Epub 2011 Sep 20. Erratum in: Cancer. 2012 Nov 1;118(21):5448.

47.

Maternal smoking during pregnancy and anger temperament among adult offspring.

Liu T, Gatsonis CA, Baylin A, Kubzansky LD, Loucks EB, Buka SL.

J Psychiatr Res. 2011 Dec;45(12):1648-54. doi: 10.1016/j.jpsychires.2011.08.007. Epub 2011 Sep 3.

48.

Reduced lung-cancer mortality with low-dose computed tomographic screening.

National Lung Screening Trial Research Team, Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, Gareen IF, Gatsonis C, Marcus PM, Sicks JD.

N Engl J Med. 2011 Aug 4;365(5):395-409. doi: 10.1056/NEJMoa1102873. Epub 2011 Jun 29.

49.

Response to treatment series: part 1 and introduction, measuring tumor response--challenges in the era of molecular medicine.

Sullivan DC, Gatsonis C.

AJR Am J Roentgenol. 2011 Jul;197(1):15-7. doi: 10.2214/AJR.11.7083. No abstract available.

PMID:
21701005
50.

Quantitative imaging test approval and biomarker qualification: interrelated but distinct activities.

Buckler AJ, Bresolin L, Dunnick NR, Sullivan DC, Aerts HJ, Bendriem B, Bendtsen C, Boellaard R, Boone JM, Cole PE, Conklin JJ, Dorfman GS, Douglas PS, Eidsaunet W, Elsinger C, Frank RA, Gatsonis C, Giger ML, Gupta SN, Gustafson D, Hoekstra OS, Jackson EF, Karam L, Kelloff GJ, Kinahan PE, McLennan G, Miller CG, Mozley PD, Muller KE, Patt R, Raunig D, Rosen M, Rupani H, Schwartz LH, Siegel BA, Sorensen AG, Wahl RL, Waterton JC, Wolf W, Zahlmann G, Zimmerman B.

Radiology. 2011 Jun;259(3):875-84. doi: 10.1148/radiol.10100800. Epub 2011 Feb 15.

Supplemental Content

Loading ...
Support Center